Prosperity Bancshares, Inc (PB) Stock News

PBE is a smart beta ETF focused on biotechnology and genome companies with $412.99 million in assets. It has delivered strong year-to-date returns of 16.68% and one-year returns of 36.23%, but carries higher risk with a standard deviation of 20.18%. The fund charges a 0.59% expense ratio and holds concentrated positions in healthcare stocks like Natera, Illumina, and Biogen. Cheaper alternatives like XBI and IBB are available for investors seeking lower-cost options.

Private Bancorp of America is expected to report Q3 2026 earnings of $2.07 per share (up 25.5% YoY) with revenues of $34.84 million (up 10.6% YoY). However, the stock carries a negative Earnings ESP of -2.42%, making it difficult to predict an earnings beat despite its Zacks Rank #2 (Buy) rating. The company beat estimates in only 2 of the last 4 quarters.

Petrobras (PBR) stock jumped 11.5% to $24.14 following Brazil's presidential election first round, where right-wing candidate Flávio Bolsonaro narrowly led incumbent Lula da Silva. Investors are optimistic about potential market-oriented policies and reduced political intervention in state-controlled companies. The company is expected to report strong quarterly earnings of $1.21 per share (+47.6% YoY) with revenues of $31.84 billion (+35.6% YoY). Consensus EPS estimates have been revised 27.4% higher over the past 30 days.

Zacks highlights four GARP (growth at a reasonable price) stocks as attractive investment opportunities in a challenging market environment marked by elevated Treasury yields and inflation concerns. The featured stocks—Marathon Petroleum, PBF Energy, Ultrapar Participacoes, and Repsol—combine reasonable valuations with solid earnings growth potential, offering a hybrid approach between value and growth investing strategies.

Zacks Premium offers investment research tools including the Zacks Rank and Style Scores to help investors identify high-performing stocks. The Zacks Rank #1 (Strong Buy) stocks have averaged +23.8% annual returns since 1988, outperforming the S&P 500. Style Scores rate stocks on value, growth, and momentum characteristics to help narrow down the best investment opportunities. PBF Energy is highlighted as a #1 Strong Buy with an A VGM Score.

Petrobras (PBR), Brazil's largest integrated energy firm, receives a #3 (Hold) rating from Zacks with a VGM Score of A. The stock shows positive momentum with a B Momentum Style Score and 1.6% gains over four weeks. One analyst raised earnings estimates for fiscal 2026, with consensus estimates increasing to $4.81 per share and an average earnings surprise of +3%.

Pitney Bowes (PBI) is highlighted as an attractive dividend investment with a 2.37% yield, significantly outperforming its industry average of 1.37%. The company has increased its annualized dividend by 33.3% year-over-year and maintains a conservative 24% payout ratio. With strong earnings growth expected (24.44% increase projected for 2026) and a Zacks Rank #1 (Strong Buy) rating, PBI presents a compelling opportunity for income investors seeking both dividend income and capital appreciation.

Zacks Investment Research showcased strong performance across its various stock rating systems and portfolios. PBF Energy and Delek US surged following Zacks Rank #1 upgrades, while the Zacks #1 Rank portfolio outperformed the S&P 500 by 2.3 percentage points year-to-date. Notable performers included Palantir (up 38.3% over 12 weeks), Adobe (up 27.6%), Thermo Fisher (up 40.2%), and Monolithic Power Systems (up 30.1% since January 5, 2026). The article emphasizes Zacks' track record of outperforming the market since 1988.

OP Bancorp (OPBK), a Los Angeles-based financial services company, is highlighted as an attractive dividend stock with a 3.63% yield, significantly higher than the industry average of 1.57%. The company has increased its annualized dividend by 16.7% year-over-year and maintains a conservative 29% payout ratio, leaving room for future growth. With expected earnings growth of 19.77% for 2026 and a Zacks Rank of #2 (Buy), OPBK presents a compelling opportunity for income investors seeking both dividend income and capital appreciation.

A $1,000 investment in PBF Energy made in September 2016 would be worth $3,645.25 as of September 14, 2026, representing a 264.53% gain that outperforms the S&P 500's 259.85% return. The independent refiner benefits from its diversified six-refinery system, improved balance sheet, and cost reduction initiatives, though risks include renewable fuel compliance costs and operational disruptions.

The article explains why brokerage analyst recommendations (ABR) should not be the sole basis for investment decisions, highlighting their positive bias due to vested interests. It contrasts ABR with Zacks Rank, a quantitative model based on earnings estimate revisions that has proven more reliable for predicting near-term stock price movements. Using Petrobras as an example, the article demonstrates how a positive ABR (1.83, approximating Buy) can differ significantly from its Zacks Rank #3 (Hold) rating.

In a comparison of two Banks - Southwest sector stocks, Prosperity Bancshares (PB) emerges as the more attractive option for value investors compared to Cullen/Frost Bankers (CFR). PB holds a Zacks Rank of #2 (Buy) versus CFR's #3 (Hold), and demonstrates superior valuation metrics including a lower forward P/E ratio of 11.25 versus CFR's 14.90, a better PEG ratio of 0.79 versus 2.49, and a lower P/B ratio of 0.88 versus 2.26. PB also earned a Value grade of B compared to CFR's C grade.

Campbell's Company reported Q4 fiscal 2026 earnings miss and announced its first dividend cut since 2001, reducing the quarterly dividend by 36% to $0.25 per share to accelerate debt reduction. The company faces headwinds from inflation, supply chain costs, and tariffs, with net sales declining 8%. For fiscal 2027, Campbell's guided earnings to decline as much as 24%, below analyst consensus expectations. Shares are down 22.8% year-to-date and trading near 5-year lows.

PBF Energy has surged 168.4% over the past year, outperforming its industry peers. The company is well-positioned to benefit from tight global product supplies, constrained refining capacity, and low product inventories, which are expected to support elevated refining margins. With a diversified refining footprint of six refineries and a Nelson Complexity Index of 12.8, PBF trades at a discount valuation of 5.03X trailing EV/EBITDA compared to the industry average of 5.61X, earning a Zacks Rank #1 (Strong Buy) rating.

Mid Penn Bancorp (MPB), a Northeast-based finance stock, offers an attractive dividend yield of 2.46% with a current annualized dividend of $0.92, up 12.2% year-over-year. The company maintains a conservative 28% payout ratio and is expected to see earnings expand 10.26% in 2026, earning a Zacks Rank #2 (Buy) rating.

Planet Labs PBC reported Q3 2026 earnings of $0.02 per share, beating consensus estimates of -$0.02 loss, with revenues of $116.05 million exceeding expectations by 10.67%. However, the stock has underperformed the S&P 500 year-to-date and carries a Zacks Rank #3 (Hold) rating. The company operates in the Satellite and Communication industry, currently ranked in the bottom 11% of industries. Paychex is expected to report Q2 2026 earnings of $1.33 per share, representing 9% year-over-year growth.

Campbell's reported quarterly earnings of $0.39 per share, missing the consensus estimate of $0.40 and falling short of year-ago earnings of $0.62. Revenue also missed expectations at $2.14 billion. The company received a Zacks Rank #4 (Sell) rating due to unfavorable estimate revisions, and shares have declined 14.7% year-to-date versus the S&P 500's 12% gain. The Food - Miscellaneous industry ranks in the bottom 20% of Zacks industries.

Prosperity Bancshares is highlighted as an attractive dividend stock with a 3.39% yield, significantly higher than the industry average of 1.53%. The company has increased its dividend 5 times over the last 5 years with an average annual increase of 4.50%, and expects solid earnings growth of 13.71% in 2026. With a Zacks Rank of #2 (Buy) and a conservative 40% payout ratio, PB represents a compelling investment opportunity for income investors.

OP Bancorp (OPBK) is highlighted as an attractive dividend investment opportunity for income investors. The company offers a 3.74% dividend yield, significantly higher than industry and S&P 500 averages, with a 16.7% year-over-year dividend increase. With a solid 29% payout ratio and expected 19.77% earnings growth for 2026, OPBK receives a Zacks Rank #2 (Buy) rating.

Prestige Consumer Healthcare (PBH) is a Zacks Rank #2 (Buy) stock benefiting from strategic acquisitions of Breathe Right and LaCorium Health, expected to add nearly 20% to its revenue base and lift fiscal 2027 guidance to $1.29-$1.315 billion. The company's e-commerce channel has grown to 18% of net sales with double-digit growth momentum. However, elevated debt levels ($2.0 billion net debt) and foreign exchange exposure pose risks to profitability.

Wall Street analysts expect Campbell to report Q4 earnings of $0.40 per share, representing a 35.5% year-over-year decline, with revenues projected at $2.15 billion, down 7.3%. The consensus EPS estimate has been revised 2.4% lower over the past 30 days. Both the Meals & Beverages and Snacks segments are expected to show significant declines in operating earnings compared to the prior year.

Ken Burns and PBS LearningMedia announced the launch of 'Ken Burns in the Classroom' on YouTube, bringing free, curriculum-aligned educational content to teachers and students. The initiative begins with three courses focused on The American Revolution, featuring professionally edited film segments and interactive materials. Additional courses from Burns's extensive filmography will follow in coming weeks.

The article compares two biotech ETFs from Invesco: IBBQ, which offers broad diversification across 251 companies with a low 0.19% expense ratio, and PBE, which takes a concentrated approach with 31 holdings and a higher 1.73% dividend yield. IBBQ is recommended for long-term investors seeking low-cost exposure, while PBE appeals to income-focused investors willing to pay higher fees for selective, momentum-driven picks.

The Vanguard Health Care ETF (VHT) offers broad healthcare exposure with a low 0.09% expense ratio and 423 holdings, while the Invesco Biotechnology & Genome ETF (PBE) provides focused biotech exposure with 31 holdings and higher growth potential. PBE delivered a stronger 40.88% one-year return but experienced greater volatility with a 37.84% maximum drawdown, while VHT returned 27.85% with lower risk. VHT suits conservative investors seeking steady, low-cost exposure, while PBE appeals to risk-tolerant investors chasing biotech innovation.

The article compares two unprofitable but rapidly growing companies: Planet Labs PBC, which operates 200+ satellites for Earth imaging, and Snowflake, a cloud data platform for AI analytics. Both face different competitive pressures and risk profiles. Planet Labs has lower valuation multiples but higher government revenue concentration, while Snowflake benefits from platform-agnostic positioning in the AI boom. The author gives a slight edge to Planet Labs for its stronger competitive moat, though neither is guaranteed long-term success.

Northrim BanCorp announced it will acquire PBCO Financial Corporation (People's Bank of Commerce) in an all-stock transaction valued at approximately $167.3 million ($32.36 per share). The merger marks Northrim's first out-of-state expansion, extending its community banking operations into Southern Oregon and the Willamette Valley. The combined entity will have over $4 billion in assets, with closing expected in Q4 2026 or early Q1 2027.

PBF Energy stock rose 10.5% this week and is up nearly 125% in 2026, driven by widening crack spreads (the difference between refined product prices and crude oil prices). The increase is fueled by geopolitical tensions in the Strait of Hormuz following the collapse of a memorandum of understanding with Iran, which restricts commercial traffic and reduces global refined product supply. This benefits PBF as a U.S. refiner that can access domestic crude while profiting from higher margins on refined products.

PBF Energy stock rose 10.6% this week following deterioration in US-Iran relations and ceasefire breakdown. The stock gained despite rising oil prices because the crack spread (difference between refined product prices and input costs) widened significantly. Supply disruptions from potential Strait of Hormuz closure benefit domestic refiners like PBF by increasing refined product prices relative to crude oil costs.

Prestige Consumer Healthcare (PBH) shares dropped over 11% on May 14, 2026, after the company reported significant revenue declines and production problems at its recently acquired Pillar5 facility. The facility, which was supposed to resolve Clear Eyes supply chain constraints, failed to deliver expected results. Q4 2026 revenues fell 5% year-over-year, with North America OTC Eye & Ear Care declining 20.6%. Hagens Berman has opened an investigation into whether the company adequately disclosed these issues to investors.

The article compares two consumer staples ETFs: XLP (State Street Consumer Staples Select Sector SPDR ETF) and PBJ (Invesco Food & Beverage ETF). XLP offers a broader consumer staples exposure with a significantly lower expense ratio (0.08% vs 0.61%), higher dividend yield (2.6% vs 1.6%), and superior 5-year performance ($1,344 vs $1,174 on $1,000 invested). PBJ focuses narrowly on food and beverage stocks with a more concentrated portfolio. Both are defensive investments with low volatility, but XLP emerges as the stronger choice for most investors due to its cost efficiency, higher returns, and larger asset base.